
Gonadorelin
Gonadorelin (GnRH)
Also called Gonadorelin, GnRH, LHRH, Factrel
A copy of the brain signal that controls the reproductive hormones
Gonadorelin is a copy of GnRH, the signal the brain sends to set the testes or ovaries working. It was approved as a diagnostic agent, and pulsed GnRH has been used in fertility medicine. It is discussed most often by men on testosterone therapy, which shuts that signal off; that use is off-label and has little trial data.
A synthetic form of gonadotropin-releasing hormone (GnRH) that stimulates the pituitary to release LH and FSH. It acts one step below kisspeptin. In pulses it switches the reproductive hormone cascade on, which is the basis of its use in fertility medicine; given continuously, it switches the same system off.
- Half-life
- About 2 to 10 minutes
- Route studied
- Intravenous, subcutaneous (label and studies)
- Status
- Approved as a diagnostic agent (Factrel); other uses are off-label
Studied in people, and well studied in preclinical models
What Gonadorelin has been studied for
The reasons people look it up, roughly in order of how often, and what research exists for each. Interest in a use is not evidence that it works; the evidence is stated under each one.
- Testicular function during testosterone therapy
- The most common reason people look it up, discussed as an alternative to hCG. It is an off-label use with limited trial data.
- Fertility
- Pulsed GnRH has been studied and used in fertility medicine for people whose own hypothalamic signal is missing.
- Diagnosis
- Its original approved use: a single dose is given under medical supervision and the hormone response measured, to see whether a problem lies in the brain or lower down.
Mechanism of Action
How Gonadorelin works
Gonadorelin drives the pituitary–gonadal axis directly:
- GnRH receptor (GNRHR) activation. It binds pituitary GnRH receptors and triggers release of luteinising hormone (LH) and follicle-stimulating hormone (FSH).
- Pulses versus continuous exposure. The pituitary responds to pulses; continuous exposure desensitises it and suppresses LH and FSH instead. Long-acting GnRH drugs used in prostate cancer rely on that suppression.
- Downstream effects. LH drives testosterone (or ovarian hormone) production and FSH supports sperm and follicle development.
Gonadorelin side effects: what studies reported
Short-acting and generally mild. The body responds to this signal in pulses; continuous exposure suppresses the system instead of stimulating it.
Most commonly reported
- Injection-site redness
- Flushing
- Headache
- Mild nausea
- Mood shifts in the first days as hormones adjust
Worth keeping an eye on
- Continuous rather than pulsed exposure suppresses the reproductive hormone system
- It has a half-life of only a few minutes
Source: Prescribing experience plus reports outside trials. This is a summary of published findings, not a complete safety profile and not medical advice. Questions about Gonadorelin belong with a licensed clinician who knows your history.
Your Genetics & Gonadorelin
The genes involved in how Gonadorelin works
Gonadorelin works through the receptors these genes build, and the genes vary from person to person. Researchers have linked some of that variation to differences in how people respond. A DNA report tells you which versions you carry.
A common variant in the FSH receptor. It is studied almost entirely in IVF, where a clinician is titrating a prescribed gonadotropin dose, and that setting does not transfer to this compound. We do not use it to predict anything about you.
The Trp8Arg variant changes LH structure and has been associated with differences in LH activity and reproductive traits in human studies. It has not been studied with gonadorelin.
This promoter variant has been associated with lower FSH levels in population studies. It describes a baseline, not a response to gonadorelin.
The PvuII variant in the oestrogen receptor gene has been studied for its association with hormone-related traits. Any link to gonadorelin is untested.
The dots after each gene are where your own result goes. Your report fills them in with the two letters you carry at that position.
Which of these variants do you carry?
Your report reads the DNA file you already have against this research.
Often discussed alongside
Compounds that come up next to Gonadorelin in research and discussion. Each has its own page. None of this is a suggestion to combine them.

Kisspeptin-10
acts one step higher in the same systemEmerging EvidenceKisspeptin-10 (Metastin fragment)
A signalling peptide at the top of the reproductive hormone axis. Kisspeptin-10 stimulates the hypothalamus to release GnRH, which in turn drives LH and FSH and then testosterone or oestrogen. It is a research tool in fertility and sexual-behaviour studies, and it is not an approved medicine.
4
Gene variants
30+
Studies
Access
Access and legal status
Gonadorelin: Approved as a diagnostic agent (Factrel); other uses are off-label. Decisions about any prescription medicine belong to a prescriber. We don't link to any seller, and nothing on this page is a recommendation to obtain or use it.
Your DNA and Gonadorelin: see which of the variants studied alongside it you carry, and what that research does and does not show. Read my DNA, $99 →
Educational information only, not medical advice. Most peptides are not FDA-approved. Do not start, stop or change any medication or peptide because of this page; talk to a licensed clinician.
Worth knowing about Gonadorelin
Interactions and situations where there is a specific reason to be careful. Where the honest answer is that nobody has studied something, it says so and says what that leaves open.
- Pulses, not a steady drip
- The same molecule stimulates or shuts down the system depending entirely on rhythm. Continuous exposure is how the prostate-cancer drugs in this family work, by design.
- A prescription-medicine setting
- Its uses involve prescription hormones and medical monitoring. Decisions about it belong to a prescriber.
Last updated
Frequently Asked Questions
Why does the rhythm of GnRH exposure matter?
The pituitary is built to respond to pulses of GnRH. Under continuous exposure its receptors desensitise and the effect flips from stimulating to suppressing LH and FSH. Long-acting GnRH drugs used in prostate cancer and endometriosis rely on that suppression.
How is Gonadorelin different from Kisspeptin-10?
Kisspeptin-10 acts one step higher: it tells the hypothalamus to release GnRH. Gonadorelin is GnRH, acting directly on the pituitary. Both raise LH and FSH in studies.
Do genes affect gonadorelin response?
No study has tested whether any genotype changes response to gonadorelin. FSHR, LHB, FSHB and ESR1 build the hormones and receptors downstream of it, and some of their variants have been associated with hormone levels or fertility traits. A DNA report can show which versions you carry and what that research does and does not show.
Watch
What clinicians and researchers say about Gonadorelin
Learn more about Gonadorelin
Your DNA and Gonadorelin
What the research says about your variants.
The report
Which Gonadorelin variants do you carry?
Your report reads the DNA file you already have against the published research on 31 peptides, marker by marker, and says what that research does and does not show.
Read my DNA, $99